Ultrasound guided conformal brachytherapy of cervix cancer: Survival, patterns of failure, and late complications

Journal of Gynecologic Oncology

Volumn 25, Issue 3, 2014, Pages 206-213

  Narayan, Kailash ^a   van Dyk, Sylvia ^a   Bernshaw, David ^a   Khaw, Pearly ^a   Mileshkin, Linda ^a   Kondalsamy Chennakesavan, Srinivas ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Brachytherapy; Cervix; Image guided radiotherapy; Neoplasms; Radiation effects

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; BLADDER TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CORPUS LUTEUM; EXTERNAL BEAM RADIOTHERAPY; FAILURE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HISTOLOGY; HUMAN; IMAGE GUIDED RADIOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REPRODUCTIVE TOXICITY; SALVAGE THERAPY; TOXICITY; TREATMENT FAILURE; TUMOR INVASION; ULTRASOUND GUIDED CONFORMAL BRACHYTHERAPY; UTERINE CERVIX CANCER; VAGINAL TOXICITY; ADENOCARCINOMA; ADVERSE EFFECTS; AGED; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIATION DOSE; RADIOGRAPHY; SECONDARY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOTHERAPY, CONFORMAL; TREATMENT FAILURE; ULTRASONOGRAPHY, INTERVENTIONAL; UTERINE CERVICAL NEOPLASMS;

EID: 84904644380     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2014.25.3.206     Document Type: Article

References (25)

1. Narayan K, McKenzie A, Fisher R, Susil B, Jobling T, Bernshaw D. Estimation of tumor volume in cervical cancer by magnetic resonance imaging. Am J Clin Oncol 2003;26:e163-8.
2. International Commission on Radiological Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda: International Commission on Radiological Units and Measurements, Inc; 1985.
3. Narayan K, van Dyk S, Bernshaw D, Rajasooriyar C, Kondalsamy-Chennakesavan S. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival. Int J Radiat Oncol Biol Phys 2009;74:1529-35.
4. Narayan K, Fisher R, Bernshaw D. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer 2006;16:623-30.
5. Narayan K, Fisher RJ, Bernshaw D. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer 2008;18:525-33.
6. Van Dyk S, Narayan K, Fisher R, Bernshaw D. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 2009;75:64-70.
7. Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 2000;46:507-13.
8. van Dyk S, Kondalsamy-Chennakesavan S, Schneider M, Bernshaw D, Narayan K. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer. Int J Radiat Oncol Biol Phys 2014;88:860-5.
9. Suit HD, Westgate SJ. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 1986;12:453-8.
10. Barkati M, Van Dyk S, Foroudi F, Narayan K. The use of magnetic resonance imaging for image-guided brachytherapy. J Med Imaging Radiat Oncol 2010;54:137-41.
11. Potter R, Dimopoulos J, Georg P, Lang S, Waldhausl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148-55.
12. Mackie TR, Kapatoes J, Ruchala K, Lu W, Wu C, Olivera G, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:89-105.
13. Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer 2003;13:657-63.
14. Narayan K, Fisher RJ, Bernshaw D, Shakher R, Hicks RJ. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer 2009;19:912-8.
15. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magne N. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010;96:161-5.
16. Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116-23.
17. Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013;52:1510-9.
18. Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012;103:113-22.
19. Narayan K, Barkati M, van Dyk S, Bernshaw D. Image-guided brachytherapy for cervix cancer: from Manchester to Melbourne. Expert Rev Anticancer Ther 2010;10:41-6.
20. Rajasooriyar C, Van Dyk S, Lindawati M, Bernshaw D, Kondalsamy-Chennakesavan S, Narayan K. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography. Int J Gynecol Cancer 2012;22:1532-7.
21. Schmid MP, Fidarova E, Potter R, Petric P, Bauer V, Woehs V, et al. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol 2013;52:1384-90.
22. Delpech Y, Haie-Meder C, Rey A, Zafrani Y, Uzan C, Gouy S, et al. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol 2007;14:3223-31.
23. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999;73:106-10.
24. Touboul C, Uzan C, Mauguen A, Gouy S, Rey A, Pautier P, et al. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist 2010;15:405-15.
25. Narayan K, vanDyk S, Bernshaw DL. In regard to correspondence between Potter et al. and Nag et al. (Int J Radiat Oncol Biol Phys 2005;62:293-295). Int J Radiat Oncol Biol Phys 2005;63:644-5.